UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins

Laboratory investigation, 2024-10, Vol.104 (10), p.102131, Article 102131

2024

Volltextzugriff (PDF)

The Role of CD276 in Cancers

Frontiers in oncology, 2021-03, Vol.11, p.654684-654684

2021

Volltextzugriff (PDF)

B7-H3/CD276: An Emerging Cancer Immunotherapy

Frontiers in immunology, 2021-07, Vol.12, p.701006-701006

2021

Volltextzugriff (PDF)

Exosomal B7-H3 facilitates colorectal cancer angiogenesis and metastasis through AKT1/mTOR/VEGFA pathway

Cellular signalling, 2023-09, Vol.109, p.110737-110737, Article 110737

2023

Volltextzugriff (PDF)

Clinical Insights Into Novel Immune Checkpoint Inhibitors

Frontiers in pharmacology, 2021-05, Vol.12, p.681320-681320

2021

Volltextzugriff (PDF)

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

Molecular cancer, 2019-11, Vol.18 (1), p.155-155, Article 155

2019

Volltextzugriff (PDF)

Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting

Cancer cell, 2019-03, Vol.35 (3), p.489-503.e8

2019

Volltextzugriff (PDF)

Soluble B7-H3 (sB7-H3) is over-expressed in the serum of type 1 diabetes patients

Diabetes research and clinical practice, 2018-09, Vol.143, p.332-336

2018

Volltextzugriff (PDF)

B7-H3 Inhibitors in Oncology Clinical Trials: A Review

Journal of Immunotherapy and Precision Oncology, 2024-02, Vol.7 (1), p.53-66

2024

Volltextzugriff (PDF)

State of the art and perspectives of chimeric antigen receptor T cells cell therapy for neuroblastoma

Cytotherapy (Oxford, England), 2024-10, Vol.26 (10), p.1122-1131

2024

Volltextzugriff (PDF)

Expression of the immune checkpoint B7-H3 in tumor and its soluble form in serum of patients with bone neoplasms

Alʹmanakh klinicheskoĭ medit͡s︡iny, 2021-07, Vol.49 (3), p.179-190

2021

Volltextzugriff (PDF)

Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells

Cancer cell, 2019-02, Vol.35 (2), p.221-237.e8

2019

Volltextzugriff (PDF)

B7-H3-targeted CAR-T cell therapy for solid tumors

International reviews of immunology, 2022-10, Vol.41 (6), p.625-637

2022

Volltextzugriff (PDF)

To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3

Biochimica et biophysica acta. Reviews on cancer, 2022-09, Vol.1877 (5), p.188783-188783, Article 188783

2022

Volltextzugriff (PDF)

Remodeling of Tumor Microenvironment by Tumor‐Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy

Small (Weinheim an der Bergstrasse, Germany), 2021-10, Vol.17 (43), p.e2102624-n/a

2021

Volltextzugriff (PDF)

B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma

Frontiers in immunology, 2022-10, Vol.13, p.1002898-1002898

2022

Volltextzugriff (PDF)

B7-H3 promotes gastric cancer cell migration and invasion

Oncotarget, 2017-09, Vol.8 (42), p.71725-71735

2017

Volltextzugriff (PDF)

Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

Cell research, 2017-08, Vol.27 (8), p.1034-1045

2017

Volltextzugriff (PDF)

Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis

Lung cancer (Amsterdam, Netherlands), 2017-01, Vol.103, p.44-51

2017

Volltextzugriff (PDF)

MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7 H3

Biochemical and biophysical research communications, 2019-01, Vol.508 (4), p.1067-1073

2019

Volltextzugriff (PDF)

Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

Neuro-oncology (Charlottesville, Va.), 2021-06, Vol.23 (6), p.999-1011

2021

Volltextzugriff (PDF)

Engineering MMP‑2 Activated Nanoparticles Carrying B7-H3 Bispecific Antibodies for Ferroptosis-Enhanced Glioblastoma Immunotherapy

ACS nano, 2023-05, Vol.17 (10), p.9126-9139

2023

Volltextzugriff (PDF)

Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3

World journal of gastroenterology : WJG, 2015-02, Vol.21 (6), p.1804-1813

2015

Volltextzugriff (PDF)

Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer

Clinical immunology (Orlando, Fla.), 2021-06, Vol.227, p.108753-108753, Article 108753

2021

Volltextzugriff (PDF)

Preconditioning of radiotherapy enhances efficacy of B7-H3-CAR-T in treating solid tumor models

Life sciences (1973), 2023-10, Vol.331, p.122024-122024, Article 122024

2023

Volltextzugriff (PDF)

1 – 25 von 406

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(371)
Mit Volltextzugriff
(381)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins

The Role of CD276 in Cancers

B7-H3/CD276: An Emerging Cancer Immunotherapy

Exosomal B7-H3 facilitates colorectal cancer angiogenesis and metastasis through AKT1/mTOR/VEGFA pathway

Clinical Insights Into Novel Immune Checkpoint Inhibitors

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting

Soluble B7-H3 (sB7-H3) is over-expressed in the serum of type 1 diabetes patients

B7-H3 Inhibitors in Oncology Clinical Trials: A Review

State of the art and perspectives of chimeric antigen receptor T cells cell therapy for neuroblastoma

Expression of the immune checkpoint B7-H3 in tumor and its soluble form in serum of patients with bone neoplasms

Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells

B7-H3-targeted CAR-T cell therapy for solid tumors

To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3

Remodeling of Tumor Microenvironment by Tumor‐Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy

B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma

B7-H3 promotes gastric cancer cell migration and invasion

Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis

MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7 H3

Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

Engineering MMP‑2 Activated Nanoparticles Carrying B7-H3 Bispecific Antibodies for Ferroptosis-Enhanced Glioblastoma Immunotherapy

Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3

Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer

Preconditioning of radiotherapy enhances efficacy of B7-H3-CAR-T in treating solid tumor models

Suchergebnisse filtern